Comparative pharmacokinetics of lividomycin, amikacin and sisomicin in normal subjects and in uraemic patients

Abstract
The present study was designed to determine the pharmacokinetics of three new aminoglycoside antibiotics in normal subjects and in uraemic patients. After a single intramuscular injection of 350 mg of lividomycin, 7 mg/kg amikacin or 1 mg/kg sisomicin, the serum half-life (T½) in normal subjects was between 1·74 and 2·23 h and the total elimination constant (Kc) between 0·312 and 0·400 h−1. In patients with renal insufficiency T½ was prolonged as renal function decreased. Patients with very severe uraemia and creatinine clearances (Ccr)T½ of between 40·20 to 56·98 h. Thirty to sixty-four per cent of an injected dose was removed during 8-h haemodialysis using a Cöil dialyser. Urinary excretion during the first 24 h after injection was 80 to 85% in normal subjects, 60% in patients with Ccr between 20 and 80 ml/min and 30% in patients with Ccr between 5 and 20 ml/min. T½ in the uraemic patients was 3 to 5 times the serum creatinine level and we therefore suggest 2 dose schedules: a full dose every 3 T½ or a reduced sustaining dose related to creatinine clearance.

This publication has 0 references indexed in Scilit: